Human Papillomavirus Vaccine (Bivalent) comment watch save
BreastfeedingGeriatricPediatric

  • TRADE NAME: Cervarix (GSK)
  • INDICATIONS: Prevention of human papillomavirus (HPV) types 16 and 18 in females aged 10–25 years old
  • CLASS: Vaccine
  • HALF-LIFE: N/A
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Immunosuppressants

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top